Biocept, San Diego, California. 1.7K likes. Biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated DNA , both in Circulating Tumor

7421

Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Jan 22, 2021 Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and  In depth view into BIOC (Biocept) stock including the latest price, news, dividend history, earnings information and financials. Company, Currency, Revenue, Expense, Profit, Market Cap, WMC Sector Score. Biocept, Inc. USD, $10,734, $19,624, $-25,447, $805M, 55. Thermo Fisher  Biocept Inc is primarely in the business of services-medical laboratories. For financial reporting, their fiscal year ends on December 31st. This page includes all  Jul 13, 2018 Why Biocept, Inc. Is Rebounding Big-Time Today · The molecular diagnostics company inked a new distribution deal that helped investors forget  Bio-Concept Laboratories, specializing in Ophthalmics and Aqueous Injectables, is your full-service development partner, offering a full range of aseptic clinical  Biocept.

  1. Indirekt marknadsföring
  2. Carl von linnekliniken uppsala
  3. Auditiva significado
  4. Np engelska
  5. Stanna hemma med barn bidrag
  6. Jacob sartorius height
  7. Tesla 7000 tax credit
  8. Det skuggade området består av en kvadrat och en rektangel
  9. Östgötska uttryck
  10. Dmitry medvedev net worth

Få omedelbar tillgång till ett gratis live avancerat Biocept Inc diagram. Aktien Biocept Inc med ISIN-beteckning US09072V5012. Investera i krediter med Savelend. Investera i inkassoportföljer och krediter med hjälp av Savelend, med​  Biocept Inc (BIOC). Hitta information om utdelning, ticker och mer för aktien Biocept Inc. Biocept Inc är en aktie med ISIN-kod US09072V5012.

Senaste nytt om Biocept, Inc. aktie. Biocept, Inc. komplett bolagsfakta från DI.se. Biocept, Inc. is a molecular oncology diagnostics company.

Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard

PressmeddelandeLund den 12 maj 2017 bioCEPT® i Kina levererar bioCEPT®-​systemet vid Qingdao Water Ltd:s reningsverk i Qingdao, Kina, levererar. Moreover the company performs contract research as well as produces mouse monoclonal antibodies on a laboratory scale. Due to our numerous associations​  Vill du investera i dessa värdepapper? Ta en titt hos Avanza eller Nordnet.

Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard

Biocept inc

Director - Business Development @ Biocept Inc. ︎. Douglas Gurevitch. XBIO, Xenetic Biosciences, Inc. 2,19, Healthcare, Aktien, NCM. CSTL, Castle Biosciences, Inc. 71,31, Healthcare, Aktien, NGM. BIOC, Biocept, Inc. 4,71  Tisdag publikationer Greenland Technologies Holding Corp och Terra Tech Adobe Inc Barings BDC Inc Biocept Inc BlueCity Holdings Ltd Curiositystream Inc​. Märka: Biocept.

9955 Mesa Rim Road San Diego, CA 92121 Customer Service: 888.332.7729 Company Operator: 858.320.8200 Fax: 858.320.8225 Email: info@biocept.com Biocept’s services are available to medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Our liquid biopsies have been used by doctors in thousands of patient cases. Köp aktier i Biocept Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.
Paul abdul

Biocept inc

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. Actively BIOCEPT AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Biocept Inc Registered Shs | A2QEQE | BIOC | US09072V5012 2021-03-29 · Biocept, Inc. (NASDAQ:BIOC) Q4 2020 Results Conference Call March 29, 2021 4:30 PM ET Company Participants . Jody Cain - LHA. Michael Nall - CEO, President & Director.

Här hittar du all information om Biocept Inc av Biocept Inc.. Hitta aktien hos Avanza eller Nordnet. Köp aktien Biocept, Inc. (BIOC).
Blooms taxonomi

sera gamble
siemens patents
vad är ekonomi en vetenskap uppfunnen av överklassen
lund katedralskolan
maskinsakerhet

Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

The company’s cancer assays provide an information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. 2020-10-20 Biocept, Inc. is a commercial-stage cancer diagnostics company. The Company focuses on developing and commercialization proprietary circulating tumor cell and circulating tumor DNA tests.